ES2068214T3 - Derivado de n2-(1-carboxi-3-fenilpropil)-l-lisina y procedimiento para producir lisinopril utilizando el compuesto. - Google Patents

Derivado de n2-(1-carboxi-3-fenilpropil)-l-lisina y procedimiento para producir lisinopril utilizando el compuesto.

Info

Publication number
ES2068214T3
ES2068214T3 ES89105882T ES89105882T ES2068214T3 ES 2068214 T3 ES2068214 T3 ES 2068214T3 ES 89105882 T ES89105882 T ES 89105882T ES 89105882 T ES89105882 T ES 89105882T ES 2068214 T3 ES2068214 T3 ES 2068214T3
Authority
ES
Spain
Prior art keywords
fenilpropil
lysine
derivative
lysinopril
carboxi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89105882T
Other languages
English (en)
Inventor
Kenji Inoue
Mitsunori Matsumoto
Satomi Takahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanegafuchi Chemical Industry Co Ltd
Original Assignee
Kanegafuchi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanegafuchi Chemical Industry Co Ltd filed Critical Kanegafuchi Chemical Industry Co Ltd
Application granted granted Critical
Publication of ES2068214T3 publication Critical patent/ES2068214T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

UN DERIVADO DEL N2 - (1 - SUBSTITUIDO - 3 - FENILPROPIL) - L - LISINA ES REVELADO Y ESTA REPRESENTADO POR LA FORMULA (I), EN DONDE R1 REPRESENTA UN GRUPO PROTECTIVO TIPO METANO O ACIL, R2 REPRESENTA UN ATOMO DE HIDROGENO, UN GRUPO ALQUIL, O UN GRUPO ARALQUIL, X REPRESENTA UN GRUPO (CN) CIANO O UN GRUPO AMINOCARBONIL (CONH2) Y LA MARCA "*" REPRESENTA LA CONFIGURACION (S) DEL ATOMO DE CARBONO TEASIMETRICO.
ES89105882T 1988-04-04 1989-04-04 Derivado de n2-(1-carboxi-3-fenilpropil)-l-lisina y procedimiento para producir lisinopril utilizando el compuesto. Expired - Lifetime ES2068214T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63083632A JPH01254651A (ja) 1988-04-04 1988-04-04 Ｎ↑２−（１−カルボキシ−３−フエニルプロピル）−ｌ−リジン誘導体及び該化合物を用いるリジノプリルの製造法

Publications (1)

Publication Number Publication Date
ES2068214T3 true ES2068214T3 (es) 1995-04-16

Family

ID=13807843

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89105882T Expired - Lifetime ES2068214T3 (es) 1988-04-04 1989-04-04 Derivado de n2-(1-carboxi-3-fenilpropil)-l-lisina y procedimiento para producir lisinopril utilizando el compuesto.

Country Status (7)

Country Link
EP (1) EP0336368B1 (es)
JP (1) JPH01254651A (es)
KR (1) KR0143418B1 (es)
CA (1) CA1329681C (es)
DE (1) DE68920896T2 (es)
ES (1) ES2068214T3 (es)
IE (1) IE66388B1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7781991A (en) * 1990-04-26 1991-11-27 Schering Corporation Diastereoselective process for preparing n-substituted amino acids and derivatives
EP0645398B1 (en) * 1993-01-08 2003-03-05 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Method of crystallizing n?2 -((s)-1-ethoxycarbonyl-3-phenylpropyl)-n?6 -trifluoroacetyl-l-lysyl-l-proline
DE4331540A1 (de) * 1993-09-17 1995-03-23 Degussa Verfahren zur Reinigung von 1-[N·2·-((S)-Ethoxycarbonyl)-3-phenylpropyl)-N·6·-trifluoracetyl]-L-lysyl-L-prolin (Lisinopril(Tfa)ethylester)
HU214579B (hu) * 1995-03-14 1998-04-28 Richter Gedeon Vegyészeti Gyár Rt. Új eljárás lizinopril előállítására
CN1053437C (zh) * 1995-07-19 2000-06-14 五洲药厂 赖诺普利合成方法
IT1299341B1 (it) * 1998-02-09 2000-03-16 Pfc Italiana Srl Processo per la produzione di alcossicarbonildipeptidi intermedi nella sintesi del lisinopril.
DE69934084T2 (de) * 1998-09-22 2007-04-05 Kaneka Corp. Verfahren zur herstellung von n2-(1(s)-carboxy-3-phenylpropyl)-l-lysyl-l-prolin
SE0000382D0 (sv) 2000-02-07 2000-02-07 Astrazeneca Ab New process
JP2003026644A (ja) 2001-07-11 2003-01-29 Kanegafuchi Chem Ind Co Ltd Ｎ２−（１（ｓ）−エトキシカルボニル−３−フェニルプロピル）−ｎ６−トリフルオロアセチル−ｌ−リジンの精製方法
CN109422797B (zh) * 2017-08-30 2023-12-19 上海科胜药物研发有限公司 一种赖诺普利中间体的制备方法
CN109422702B (zh) * 2017-08-30 2023-04-18 上海科胜药物研发有限公司 赖诺普利中间体及其纯化方法
CN111285919B (zh) * 2018-12-06 2022-07-12 浙江昌明药业有限公司 一种赖诺普利二聚物的制备方法、其中间体及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU569789B2 (en) * 1984-05-03 1988-02-18 Brigham And Women's Hospital A.c.e. inhibitors to treat renal diseases
EP0168769A3 (en) * 1984-07-16 1989-02-08 Merck & Co. Inc. Process for preparing carboxyalkyl dipeptides
US4652668A (en) * 1985-07-03 1987-03-24 Biomeasure, Inc. Aromatic amino acid derivatives

Also Published As

Publication number Publication date
EP0336368A3 (en) 1990-12-05
DE68920896T2 (de) 1995-05-24
KR890016060A (ko) 1989-11-28
EP0336368A2 (en) 1989-10-11
JPH01254651A (ja) 1989-10-11
KR0143418B1 (ko) 1998-07-15
CA1329681C (en) 1994-05-17
DE68920896D1 (de) 1995-03-16
EP0336368B1 (en) 1995-02-01
JPH0576943B2 (es) 1993-10-25
IE891062L (en) 1989-10-04
IE66388B1 (en) 1995-12-27

Similar Documents

Publication Publication Date Title
ES2068214T3 (es) Derivado de n2-(1-carboxi-3-fenilpropil)-l-lisina y procedimiento para producir lisinopril utilizando el compuesto.
CO4410321A1 (es) Compuestos ciclicos condensados con funciones aminoacidas sustituidas y derivados ester de los mismos
ES2062009T4 (es) Agentes antifungicos derivados de triazol
ECSP941066A (es) Derivados de 1.5 benzodiazepina
CO5180649A1 (es) Antagonistas de los receptores de los glucocorticoides para el tratamiento de la diabetes para el tratamiento de la diabetes
ES2194314T3 (es) Derivados de benzopirano sustituidos para el tratamiento de inflamaciones.
CO4440628A1 (es) Derivados de pirimidina condensados con un anillo heteroci- clico
ES2185665T3 (es) Derivados de benzofurano como antagonistas de taquicininas.
ES2031513T3 (es) Quinazolindionas y piridopirimidinadionas.
ES2032749T3 (es) Acidos oxoftalazinil-aceticos heterociclicos.
ES2174989T3 (es) Pirido(3,2-e)pirazinonas con antiasmatica y procedimiento para su preparacion.
ES2155566T3 (es) Uso de derivados de rifamicina para el tratamiento de enfermedades infecciosas por clamidia.
DE3851179D1 (de) Oxetanocin.
ES2064487T3 (es) Nuevos inhibidores de glicosidasa.
ES2099206T3 (es) Derivados de benceno que favorecen la produccion del factor de crecimiento de los nervios humanos.
DE68909548D1 (de) Organische hydrazin-verbindungen fuer pharmazeutische anwendung.
UY25211A1 (es) Inhibidores de isoquinolinilguanidina uroquinasa
DK0538192T3 (da) Hidtil ukendte 17beta-substituerede aza-androstan-derivater
ES2081314T3 (es) Compuestos de diaminoetileno.
AR006991A1 (es) Analogo hidrosoluble de 20(s)- camptotecina, una composicion farmaceutica que los contiene, una medicina para el tratamiento del cancer, leucemia oestados relacionados con el hiv, el uso de dichos compuestos y un procedimiento para su preparacion
ES8600265A1 (es) Procedimiento para la obtencion de benzofuranos o bien 2,3-dihidrobenzofuranos
CO5080758A1 (es) DERIVADOS DE 3-(2-oxo-[1,3´]BIPIRROLODINIL-3-ILIDENMETIL
DE69231466T2 (de) Enantiomere von cyclopenten-derivaten
ES2045282T3 (es) Un procedimiento para la preparacion de antraciclinona 4-sustituida.
CO5021214A1 (es) Derivado del acido 2-metilpropionico y composicion farmaceutica que lo contiene

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 336368

Country of ref document: ES